Wade Alan Weaver, | |
1531 E Main St, Booneville, AR 72927-4921 | |
(479) 675-3900 | |
(479) 675-5909 |
Full Name | Wade Alan Weaver |
---|---|
Gender | Male |
Speciality | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist |
Location | 1531 E Main St, Booneville, Arkansas |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1538803374 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1835P0018X | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist | PD15764 (Arkansas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Wade Alan Weaver, 1531 E Main St, Booneville, AR 72927-4921 Ph: (479) 675-3900 | Wade Alan Weaver, 1531 E Main St, Booneville, AR 72927-4921 Ph: (479) 675-3900 |
News Archive
Use of bioprosthetic heart valves has dramatically increased (from 18% in 1991 to 59% in 2003), mainly in older patients with comorbidities. This is due to the increased risk of bleeding complications associated with lifelong use of anticoagulation for mechanical prostheses.
In the September 15th issue of Genes & Development, Drs. Richard T. Williams, Willem den Besten, and Charles J. Sherr at Howard Hughes Medical Institute, St. Jude Children's Research Hospital in Memphis TN, lend new insights into how an aggressive form of acute lymphoblastic leukemia (ALL) develops, and how sensitivity to the targeted chemotherapeutic drug, imatinib, can be diminished through interactions between tumor cells and the host microenvironment.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced that it has extended its drug discovery and development collaboration with Allergan, Inc..
A new study in mice reveals that increased body weight and high blood sugar as a result of consuming a high-fat diet may cause anxiety and depressive symptoms and measurable changes in the brain.
A study led by investigators at Beth Israel Deaconess Medical Center (BIDMC) has demonstrated that a new immunohistochemical test is reliable in diagnosing a dangerous arrhythmic heart disease known as arrhythmogenic right ventricular cardiomyopathy (ARVC.) Reported in the March 12 issue of The New England Journal of Medicine ( NEJM ), the new findings offer the possibility of a highly sensitive and specific means of identifying this life- threatening condition at an early stage, when it can be treated with by implanting a cardiac defibrillator.
› Verified 9 days ago
Andrea Daniel, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1400 E Main St, Booneville, AR 72927 Phone: 479-675-5341 | |
Jackson Brett Allen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1400 E Main St, Booneville, AR 72927 Phone: 479-675-5341 Fax: 479-675-3400 | |
Orville Moses Geddes, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1531 E Main St, Booneville, AR 72927 Phone: 479-675-3900 |